ArticleJournal of clinical medicine2024

Evolocumab Treatment in Dyslipidemic Patients Undergoing Coronary Artery Bypass Grafting: One-Year Safety and Efficacy Results.

Giuseppe Nasso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.